Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
iSYNAPSE: Immunosuppression Reduction in Pediatric Liver Transplant Recipients
NCT07549503Phase 2Recruiting
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- May 2026
- Primary completion
- Apr 2031
- Countries
- 1
01
Overview
A Phase 2 trial of tacrolimus + Wuzhi capsule in liver transplant, sponsored by National Institute of Allergy and Infectious Diseases. Started May 2026; status: recruiting.
02
Drugs
tacrolimus + Wuzhi capsule
03
Conditions
liver transplant
Beyond the preview
Go deeper on NCT07549503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07549503.